Estech is a San Ramon, California–based medical device company focused on a minimally invasive cardiac ablation platform that allows surgeons to treat atrial fibrillation endoscopically through three small chest ports. The procedure typically takes 60–90 minutes and, in some cases, can be performed under epidural rather than general anesthesia. The device holds a CE mark in Europe for treating atrial fibrillation and has received FDA 510(k) clearance for cardiac ablation in the United States. Estech’s technology aims to shorten procedure times and reduce patient trauma compared with traditional open-heart ablation surgeries. The company plans to use newly raised capital to advance further development of its platform. Over the past two years, Estech has secured more than $28 million in total funding, underscoring sustained investor confidence in its solution.

Total raised

$28M

Funding rounds

3

Latest round

Equity

Latest activity

Dec 2010